Shares Of Mylan Slightly Higher Following Launch Of Generic Drug

Shares of Mylan NV (NASDAQ: MYL) were trading higher by 0.85 percent early Tuesday morning after the company announced the launch of Linezolid Tablets, 600 mg.

Linezolid is a generic version of Pfizer Inc. (NYSE: PFE)'s Zyvox Tablets and is intended for adults and children for the treatment of certain infections caused by susceptible Gram-positive bacteria.

Mylan noted that it has already received final approval from the U.S. Food and Drug Administration. The company added that Linezolid Tablets had U.S. sales of approximately $457.8 million for the 12 months ending September 30, 2015, according to IMS Health.